行情

IBIO

IBIO

IBIO
AMEX

实时行情|Nasdaq Last Sale

1.230
-0.060
-4.65%
盘后: 1.230 0 0.00% 19:50 04/16 EDT
开盘
1.280
昨收
1.290
最高
1.290
最低
1.220
成交量
472.32万
成交额
--
52周最高
7.45
52周最低
0.8555
市值
2.66亿
市盈率(TTM)
-6.7434
分时
5日
1月
3月
1年
5年
2027年跨行业的交易和分析需求中基于植物的生物制品市场的增长
Apr 10, 2021 (Market Insight Reports) -- Global Plant-based Biologics Market Rising demand for human biologics cannot be fulfilled by currently used...
Market Insight Reports · 04/10 10:51
人乳头瘤病毒蛋白E7市场：全球行业趋势，份额，规模，增长，行业统计，机会和预测2021-2027
Apr 09, 2021 (Market Stats News via COMTEX) -- The latest report as Human Papillomavirus Protein E7 Market acknowledges Size, Application Segment, Type,...
Market Stats News · 04/09 06:30
冠状病毒（COVID 19）疫苗管道评估规模，份额，行业报告，趋势，增长和预测2020-2025
Japan, Japan, Fri, 09 Apr 2021 01:33:18 / Comserve Inc. / -- Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020" provides a comprehensive analysis of...
Comserve · 04/09 05:35
与竞争对手相比，iBio Inc.的股票周一表现不佳
marketwatch.com · 04/05 20:59
主要参与者对黄热病治疗市场的综合研究：赛诺菲巴斯德公司，Bio-Manguinhos，达喀尔巴斯德研究所，FSUE Chumakov等…
Apr 01, 2021 (MARKITWIRED via COMTEX) -- Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and...
Markitwired · 04/01 10:33
人乳头瘤病毒蛋白E7市场分析，最新趋势，发展，顶尖公司和预测Ameco Research的2020-2027
pune, India, Tue, 30 Mar 2021 02:52:43 / Comserve Inc. / -- Ameco Research indicates that the Global Human Papillomavirus Protein E7 Market is expected to...
Comserve · 03/31 13:09
iBio Inc.周二股价下跌，跑输大盘
Shares of iBio Inc. shed 3.85% to $1.50 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite...
marketwatch.com · 03/30 21:00
iBio Inc.周一股价下跌，跑输大盘
Shares of iBio Inc. slid 3.70% to $1.56 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial...
marketwatch.com · 03/29 21:00
更多
财务预测
实际值（美元）
预测值（美元）
利润表更多
净利润（美元）
同比（%）
资产负债表更多
总资产（美元）
总负债（美元）
资产负债率（%）
现金流表更多
经营现金流（美元）
同比（%）
了解IBIO最新的财务预测，通过IBIO每股收益，每股净资产，每股现金流等数据分析IBIO近期的经营情况，然后做出明智的投资选择。
分析师评级

2位分析师的综合评级

买入

免责声明：分析师观点仅供投资者决策参考，不构成任何买卖投资建议。

目标价格预测
分析师预测IBIO价格均价为2.500，最高价位3.000，最低价为2.000。
EPS
机构持股
总机构数: 16
机构持股: 33.22万
持股比例: 0.15%
总股本: 2.16亿
类型机构数股数
增持
4
1.41万
建仓
2
1.98万
减持
3
6,983
平仓
1
250
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
+0.98%
制药与医学研究
+0.89%
高管信息
Chairman/President/Chief Executive Officer/Director
Thomas Isett
Chief Financial Officer/Chief Accounting Officer
Robert Lutz
Chief Operating Officer
Randy Maddux
Chief Scientific Officer
Martin Brenner
Treasurer/Secretary/Director
Robert Kay
Independent Director
Linda Armstrong
Independent Director
Glenn Chang
Independent Director
Seymour Flug
Independent Director
James Hill
Independent Director
Alexandra Kropotova
Independent Director
John McKey
Independent Director
Gary Sender
暂无数据
  • 全部
  • 财务报告
  • 内部人交易
更多
IBIO 简况
iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The Company is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The Company's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma.

微牛提供Ibio Inc(AMEX-IBIO)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的IBIO股票新闻，以帮助您做出投资决策。

模拟交易：模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易IBIO股票基本功能。